CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 504 enrolled
Drug / intervention
in daily everyday routine practicedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04656847
NCT04656847N/ACompleted
CompareCT.gov

Assessment of the Efficacy, Adherence and Tolerability of the Single Pill Combination Bisoprolol/PerindopRil In Patients With Previous Myocardial Infraction With Arterial Hypertension in the Daily Clinical practicE

Servier Russia·observational·Posted Dec 7, 2020·Updated Nov 1, 2024

In Brief

An observational study evaluating in daily everyday routine practice for Coronary Artery Disease and 2 related conditions. Completed, enrolled 504 participants across 1 site.

Detailed Summary

This non-interventional, ambispective study was aimed at evaluating the effectiveness, safety, and tolerability of bisoprolol and perindopril SPC in previous myocardial infarction patients with HTN and CAD treated with the drug for 12 weeks in the daily clinical practice. SPC will be used according to the approved instruction for medical use of the medicine. This is a multi-centre, observational, incomparative, ambispective study, which will retrospectively and prospectively collect clinical variables and socio-demographic data from medical records of patients with HTN and previous MI initiated with bisoprolol/perindopril SPC in real life settings.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Myocardial Infarction, Arterial Hypertension
CountriesRussia
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 7, 2020
Enrollment StartMar 1, 2021
Primary CompletionOct 5, 2021
Study CompletionOct 18, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.6 years ago

Interventions

in daily everyday routine practicedrug

patients with HTN and CAD treated with the the single pill combination bisoprolol/perindopril for 12 weeks in the daily clinical practice Retrospective screening and evaluation of patient's eligibility to inclusion/ exclusion criteria for entering the study allows mitigating a potential risk of deliberative medicine administration within the observational program.